REDWOOD CITY, Calif., June 1, 2020 /PRNewswire/ -- AcelRx Pharmaceuticals, Inc. (Nasdaq: ACRX), a specialty pharmaceutical company focused on the development and commercialization of innovative therapies for the use in medically supervised settings, today announced that management will be providing an overview of the business and company updates at the Jeffries Virtual Healthcare Conference to be held June 2 at 1:30 p.m. ET (10:30 a.m. PT). A live webcast link of the event can be found on the Company's website at http://ir.acelrx.com/upcoming-events. Management will also be hosting one-on-one investor meetings throughout the day.
For those not available to listen to the live webcast, a replay will be archived for 90 days and available through the Investors page on www.acelrx.com.
More on The Californer
About AcelRx Pharmaceuticals, Inc.
AcelRx Pharmaceuticals, Inc. is a specialty pharmaceutical company focused on the development and commercialization of innovative therapies for use in medically supervised settings. AcelRx's proprietary, non-invasive sublingual formulation technology delivers sufentanil with consistent pharmacokinetic profiles. The Company has one approved product in the U.S., DSUVIA® (sufentanil sublingual tablet, 30 mcg), known as DZUVEO in Europe, indicated for the management of acute pain severe enough to require an opioid analgesic for adult patients in certified medically supervised healthcare settings, and one product candidate, Zalviso® (sufentanil sublingual tablet system, SST system, 15 mcg) being developed as an innovatively designed patient-controlled analgesia (PCA) system for reduction of moderate-to-severe acute pain in medically supervised settings. DZUVEO and Zalviso are both approved products in Europe. Zalviso is not approved in the U.S. For additional information about AcelRx, please visit www.acelrx.com.
SOURCE AcelRx Pharmaceuticals, Inc.
Related Links
www.acelrx.com
For those not available to listen to the live webcast, a replay will be archived for 90 days and available through the Investors page on www.acelrx.com.
More on The Californer
- The Fertile Void Podcast returns for Season Two, The Coveted Silk
- R&B/Pop Recording Artist Tanya Nolan Set to Release EDM Remix of 'No Pressure'
- City of San Miguel de Allende, State of Guanajuato Obtain Coveted WTTC 'Safe Travels' Stamp
- NINICO Communications™ named top public relations agency by Los Angeles Business Journal
- Black Cultural Events Celebrates 200th Weekly Newsletter Issue
About AcelRx Pharmaceuticals, Inc.
AcelRx Pharmaceuticals, Inc. is a specialty pharmaceutical company focused on the development and commercialization of innovative therapies for use in medically supervised settings. AcelRx's proprietary, non-invasive sublingual formulation technology delivers sufentanil with consistent pharmacokinetic profiles. The Company has one approved product in the U.S., DSUVIA® (sufentanil sublingual tablet, 30 mcg), known as DZUVEO in Europe, indicated for the management of acute pain severe enough to require an opioid analgesic for adult patients in certified medically supervised healthcare settings, and one product candidate, Zalviso® (sufentanil sublingual tablet system, SST system, 15 mcg) being developed as an innovatively designed patient-controlled analgesia (PCA) system for reduction of moderate-to-severe acute pain in medically supervised settings. DZUVEO and Zalviso are both approved products in Europe. Zalviso is not approved in the U.S. For additional information about AcelRx, please visit www.acelrx.com.
SOURCE AcelRx Pharmaceuticals, Inc.
Related Links
www.acelrx.com
Filed Under: Business
0 Comments
Latest on The Californer
- Law Offices of Charles G. Eichinger & Associates, P.C. Open and Ready to Help
- American Association for Critical Illness Insurance Announces New Initiative
- Kylie Eaton's Kinetic Film Selected for Indy Short's Indiana Spotlight Program
- New San Diego Office to Launch Snell & Wilmer's First Podcast, CalCurrent
- Torres Law Joins Alliott Group, The World's Sixth-Largest Multidisciplinary Alliance Of Professional Services Firms
- Sequel in Historical Fiction Series Follows Secrets, Murder and Treason During American Civil War
- "Three Best Rated" Names Palmer a Top 3 Advertising Agency in San Francisco
- Citadel Roofing & Solar Introduces Home Generator Products
- Senseeker Establishes In-House Wafer Testing Capability
- CEO Coaching International Congratulates Its Client Jamie Donnelly on CFO of the Year Award
- Heap Names Lynn Girotto As Chief Marketing Officer
- California League of Schools Names Cathy Perry as Executive Director
- Summit Funding, Inc. Opens New Branch in Red Bluff, California
- The Playdate Dilemma Many Face
- James J. Hoover named to Advisory Board of WomenSV, a nonprofit serving survivors of domestic abuse
- Improving Parenting Skills Today
- Bilingual Montessori Preschool Is Open Using Social Distance Learning
- AUA College of Medicine Launches International Track for UK Medical Students
- Personal Hygiene Tips for Kids
- CMC Group Inc. Announces Senior Leadership Transition